Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Tackling Racial Disparities in HCV Care: Global Edition

Listen as expert faculty, Prof Ashley Brown, BSc, MD, FRCP, and Ahmed M. Elsharkawy, PhD, FRCP(UK), discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial minorities globally with or at risk for hepatitis C.
Prof Ashley Brown, BSc, MD, FRCP
person default
Ahmed M. Elsharkawy, PhD, FRCP(UK)
Released: November 17, 2021

In this episode, Prof Ashley Brown, BSc, MD, FRCP, and Ahmed M. Elsharkawy, PhD, FRCP(UK), discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial minorities globally with or at risk for hepatitis C.

Topics include:
  • HCV Burden and Care Disparities in Specific Populations
  • Genotypes and Length of Infection in Ethnic Minorities
  • Primary Care Education and System-Related Barriers
  • Solutions to Overcome Barriers to HCV Care
  • First-hand Patient Stories

Information on this Educational Activity

Faculty

Prof Ashley Brown, BSc, MD, FRCP

Professor of Practice, Viral Hepatitis
Division of Metabolism, Digestion and Reproduction
Imperial College London
Consultant Hepatologist
Liver & Antiviral Unit
Imperial College Healthcare NHS Trust
London, United Kingdom

Prof Ashley Brown, BSc, MD, FRCP, has disclosed that he has received consulting fees from AbbVie and fees for non-CME/CE services from AbbVie and Cepheid.
Ahmed M. Elsharkawy, PhD, FRCP(UK)

Consultant Hepatologist and Honorary Senior Lecturer
Liver Unit and Biomedical Research Centre
University Hospitals Birmingham
University of Birmingham
Birmingham, United Kingdom

Ahmed M. Elsharkawy, PhD, FRCP(UK), has disclosed that he has received consulting fees from Gilead Sciences, Sobi, and Shionogi and fees for non-CME/CE services from Gilead Sciences and Sobi.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options. LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP

Related Content

Dr Nancy Reau discusses her take on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 2, 2022

Expert summaries of key data in older patients with HBV, from Clinical Care Options (CCO)

Graham R. Foster, FRCP, PhD Nancy Reau, MD Released: November 16, 2022

Expert selections of important viral hepatitis data from AASLD 2022, including studies of patients with HBV, HDV, and HCV, from Clinical Care Options (CCO)

Nancy Reau, MD Stefan Zeuzem, MD Released: November 16, 2022

Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in China, from Clinical Care Options (CCO)

person default Dee Lee person default Jie Li, MD, PhD Released: October 4, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings